AmeriCann, Inc. (ACAN)
- Previous Close
0.0610 - Open
0.0750 - Bid --
- Ask --
- Day's Range
0.0652 - 0.0750 - 52 Week Range
0.0510 - 0.4150 - Volume
22,960 - Avg. Volume
9,856 - Market Cap (intraday)
1.59M - Beta (5Y Monthly) 1.48
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0100 - Earnings Date May 15, 2024 - May 19, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
AmeriCann, Inc. designs, develops, leases, and operates cannabis cultivation, processing, and manufacturing facilities in the United States. The company engages in the product manufacturing and greenhouse cultivation facilities for licensed cannabis business. Its flagship project is the Massachusetts Cannabis Center that is developed on a 52-acre parcel of land located in Freetown, southeastern Massachusetts. The company also provides medical cannabis and adult-use cannabis. The company was formerly known as Nevada Health Scan, Inc. and changed its name to AmeriCann, Inc. in 2014. AmeriCann, Inc. was incorporated in 2010 and is headquartered in Denver, Colorado.
www.americann.co3
Full Time Employees
September 30
Fiscal Year Ends
Sector
Industry
Recent News: ACAN
Performance Overview: ACAN
Trailing total returns as of 4/19/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ACAN
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ACAN
Valuation Measures
Market Cap
1.49M
Enterprise Value
9.98M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.65
Price/Book (mrq)
0.27
Enterprise Value/Revenue
4.35
Enterprise Value/EBITDA
11.07
Financial Highlights
Profitability and Income Statement
Profit Margin
-12.62%
Return on Assets (ttm)
1.50%
Return on Equity (ttm)
-5.10%
Revenue (ttm)
2.29M
Net Income Avi to Common (ttm)
-289.5k
Diluted EPS (ttm)
-0.0100
Balance Sheet and Cash Flow
Total Cash (mrq)
807.61k
Total Debt/Equity (mrq)
167.93%
Levered Free Cash Flow (ttm)
-25.56k